“ Analysis of spironolactone polymorphs in active pharmaceutical ingredients and their effect on tablet dissolution profiles ”, Braz. J. Pharm. Sci., vol. 52, no. 4, pp. 613–621, Dec. 2016, doi: 10.1590/s1984-82502016000400005.